Orthopedic surgery-induced cognitive dysfunction is mediated by CX3CL1/R1 signaling
Open Access
- 15 April 2021
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 18 (1) , 1-14
Abstract
Background: Postoperative pain is a common phenomenon after surgery and is closely associated with the development of postoperative cognitive dysfunction (POCD). Persistent pain and systemic inflammation caused by surgery have been suggested as key factors for the development of POCD. Fractalkine (CX3CL1) and its receptor, the CX3C chemokine receptor 1 (CX3CR1), are known to play a key role in pain and inflammation signaling pathways. Recent studies have shown that the regulation of CX3CR1/L1 signaling influences the development of various diseases including neuronal diseases. We determined whether CX3CR1/L1 signaling is a putative therapeutic target for POCD in a mouse model. Methods: Adult (9–11 weeks) male mice were treated with neutralizing antibody to block CX3CR1/L1 signaling both before and after surgery. Inflammatory and behavioral responses including pain were assessed postoperatively. Also, CX3CR1 mRNA level was assessed. Hippocampal astrocyte activation, Mao B expression, and GABA expression were assessed at 2 days after surgery following neutralizing antibody administration. Results: The behavioral response indicated cognitive dysfunction and development of pain in the surgery group compared with the control group. Also, increased levels of pro-inflammatory cytokines and CX3CR1 mRNA were observed in the surgery group. In addition, increased levels of GABA and increased Mao B expression were observed in reactive astrocytes in the surgery group; these responses were attenuated by neutralizing antibody administration. Conclusions: Increased CX3CR1 after surgery is both necessary and sufficient to induce cognitive dysfunction. CX3CR1 could be an important target for therapeutic strategies to prevent the development of POCD.Keywords
Funding Information
- National Research Foundation of Korea (2017R1A2B4009478, 2020R1A2C1012017)
This publication has 78 references indexed in Scilit:
- Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stageOpen Biology, 2013
- Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitisJournal of Neuroinflammation, 2012
- Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive declineProceedings of the National Academy of Sciences, 2010
- Glial and neuronal control of brain blood flowNature, 2010
- Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain AgingNeuron, 2010
- Targeting Astrocyte Signaling for Chronic PainNeurotherapeutics, 2010
- Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signallingCardiovascular Research, 2009
- Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkineBrain, Behavior, and Immunity, 2007
- Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painProceedings of the National Academy of Sciences, 2007
- Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaquesJournal of Clinical Investigation, 2007